Dr. Daniel Mark Cline, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 101 Nw Englewood Rd, Gladstone, MO 64118 Phone: 816-453-1818 |
Dr. Bruce A Kauk, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6080 N. Oak Trafficway, Gladstone, MO 64118 Phone: 816-453-9232 Fax: 816-455-2423 |
Paul C. Vescovo Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5601 N. Antioch, Creekwood Family Care, Ste. 12, Gladstone, MO 64119 Phone: 816-452-8000 Fax: 816-455-2382 |
News Archive
By taking advantage of the signature frequency by which organic and inorganic molecules absorb light, the team of researchers, led by Luke Lee, professor of bioengineering and director of UC Berkeley's Biomolecular Nanotechnology Center, can determine in real time whether specific enzymes are activated or particular genes are expressed, all with unprecedented resolution within a single living cell.
Waist circumference gives a better prediction of diabetes risk than does BMI. This is the conclusion drawn by Silke Feller and her colleagues from the German Institute for Nutritional Research in Potsdam-Rehbr-cke, in the current edition of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107[26]: 470-6).
A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual collaborations between MGH and MIT investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.
CardioFocus, a venture capital-backed medical device company developing technology to treat cardiac disorders, has secured $5M in debt financing from Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide. CardioFocus will use the new financing to initiate its pivotal trial in the United States and to expand the commercialization of its products in Europe.
› Verified 8 days ago